{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:38:11Z","timestamp":1792874291924,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.gore.2026.102201","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:45:14Z","timestamp":1787931914000},"page":"102201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Markedly elevated alpha-fetoprotein leading to the diagnosis of high-grade endometrial carcinoma during hepatocellular carcinoma surveillance"],"prefix":"10.1016","volume":"67","author":[{"given":"Jayati","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence Hsu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloofar O.","family":"Karbasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annekathryn","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2026.102201_bb0005","series-title":"StatPearls","article-title":"Alpha-fetoprotein analysis","author":"Adigun","year":"2026"},{"issue":"3","key":"10.1016\/j.gore.2026.102201_bb0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/jclinpath-2017-204535","article-title":"Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis","volume":"71","author":"Arora","year":"2018","journal-title":"J. Clin. Pathol."},{"issue":"11","key":"10.1016\/j.gore.2026.102201_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05372","article-title":"Signs and symptoms associated with uterine cancer in pre- and postmenopausal women","volume":"6","author":"Boeckstaens","year":"2020","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.gore.2026.102201_bb0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"PORTEC Study Group. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.gore.2026.102201_bb0025","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial","volume":"20","author":"de Boer","year":"2019","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.gore.2026.102201_bb0030","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3748\/wjg.v28.i2.216","article-title":"Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma","volume":"28","author":"Hanif","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.gore.2026.102201_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.prro.2022.09.002","article-title":"Radiation therapy for endometrial Cancer: an American Society for Radiation Oncology clinical practice guideline","volume":"13","author":"Harkenrider","year":"2023","journal-title":"Pract. Radiat. Oncol."},{"issue":"18","key":"10.1016\/j.gore.2026.102201_bb0040","article-title":"Role of alpha-fetoprotein (AFP) in diagnosing childhood cancers and genetic-related diseases","volume":"24","author":"Kaczmarek-Borowska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.gore.2026.102201_bb0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/PAS.0b013e31823aafec","article-title":"Histologic and immunohistochemical analyses of \u03b1-fetoprotein\u2013producing cancer of the stomach","volume":"36","author":"Kinjo","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.gore.2026.102201_bb0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3892\/ol_00000043","article-title":"\u0391-Fetoprotein-producing endometrial adenocarcinoma without an obvious hepatoid component","volume":"1","author":"Kodama","year":"2010","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.gore.2026.102201_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2026.100976","article-title":"Endometrial carcinomas with a somatically derived yolk sac tumor component share molecular similarities to p53-abnormal endometrial carcinomas and germ cell tumors","volume":"39","author":"Li","year":"2026","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.gore.2026.102201_bb0060","article-title":"Molecular profiling of hepatoid adenocarcinoma and adenocarcinoma with enteroblastic differentiation","volume":"64","author":"Matsumoto","year":"2025","journal-title":"Surg. Oncol."},{"issue":"3","key":"10.1016\/j.gore.2026.102201_bb0065","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/PAS.0000000000000116","article-title":"SALL4 expression in germ cell and non\u2013germ cell tumors: a systematic immunohistochemical study of 3215 cases","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.gore.2026.102201_bb0070","article-title":"\u03b1-Fetoprotein-producing endometrial carcinoma is associated with fetal gut-like and\/or hepatoid morphology, lymphovascular infiltration, TP53 abnormalities, and poor prognosis: five cases and literature review","volume":"8","author":"Otani","year":"2021","journal-title":"Front Med (Lausanne)."},{"issue":"12","key":"10.1016\/j.gore.2026.102201_bb0075","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/s41379-022-01156-x","article-title":"HER2-amplified endometrial carcinoma and AFP-producing endometrial carcinoma","volume":"35","author":"Otani","year":"2022","journal-title":"Mod. Pathol."},{"issue":"21","key":"10.1016\/j.gore.2026.102201_bb0080","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage endometrial cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.gore.2026.102201_bb0085","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/ijgc-00009577-200605000-00076","article-title":"A case of alpha-fetoprotein-producing adenocarcinoma of the endometrium with a hepatoid component as a potential source for alpha-fetoprotein in a postmenopausal woman","volume":"16","author":"Takeuchi","year":"2006","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926001815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926001815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:25:01Z","timestamp":1792873501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578926001815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":17,"alternative-id":["S2352578926001815"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2026.102201","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markedly elevated alpha-fetoprotein leading to the diagnosis of high-grade endometrial carcinoma during hepatocellular carcinoma surveillance","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2026.102201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102201"}}